# Use of Stromal Vascular Fraction in Multiple Sclerosis

> **NCT03461419** · NA · SUSPENDED · sponsor: **Healeon Medical Inc** · enrollment: 100 (estimated)

## Conditions studied

- Multiple Sclerosis
- Autoimmune

## Interventions

- **PROCEDURE:** Microcannula Harvest Adipose Stroma
- **DEVICE:** Centricyte 1000
- **PROCEDURE:** Sterile Normal Saline IV Deployment of cSVF

## Key facts

- **NCT ID:** NCT03461419
- **Lead sponsor:** Healeon Medical Inc
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2019-08-01
- **Primary completion:** 2027-01-01
- **Final completion:** 2028-12-15
- **Target enrollment:** 100 (ESTIMATED)
- **Why stopped:** Withdrawn \[COVID restrictions prevent patient enrollment or treatment. Clinical Trial facility is being closed due to viral limitations and loss of staff to perform\]
- **Last updated:** 2025-09-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03461419

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03461419, "Use of Stromal Vascular Fraction in Multiple Sclerosis". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT03461419. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*